Morning gaps w/volume $DARE pop and fade after Dare Bioscience shares are trading higher after the company announced an exclusive licensing agreement with Bayer for US commercial rights to Ovaprene. Dare will receive an upfront payment of $20 million and up to $310 million in milestones. $ADAP Adaptimmune Announces that SPEAR T-cell Platform Delivers Initial Responses in Four Solid Tumor Indications $VRNA Adaptimmune Announces that SPEAR T-cell Platform Delivers Initial Responses in Four Solid Tumor Indications $LMFA announces Engagement of Maxim Group, LLC for Strategic Advisory Services and Sale of IIU, Inc $MREO shares are trading higher after the company announced it has entered into a global licensing agreement with Oncologie for Navicixizumab. Mereo will receive an upfront payment of $4 million with an additional $2 million payment conditional on CMC milestone and up to $300 million in future milestones. volume and short float stats updated daily @ bullishbears.com/trade-idea...
  • 2